Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Genetics of Drug Metabolism”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT05945784
What this trial is testing

Exploring Accessible Beauty for Individuals With Upper Extremity Deficits

Who this might be right for
Stroke, IschemicStroke HemorrhagicStroke (CVA) or TIA+11 more
Casa Colina Hospital and Centers for Healthcare 57
Not applicableStudy completedNCT00001999
What this trial is testing

A Pilot Study to Obtain Preliminary Information Regarding the Efficacy and Safety of the Combination of Immune Globulin and Ganciclovir as Compared to Ganciclovir Alone in the Treatment of Sight-Threatening CMV Retinitis in Patients With AIDS

Who this might be right for
Cytomegalovirus RetinitisHIV Infections
American National Red Cross
Testing effectiveness (Phase 2)Study completedNCT02583672
What this trial is testing

Role of Oxidative Stress and Inflammation in Type 1 Gaucher Disease (GD1)

Who this might be right for
Gaucher Disease Type 1
University of Minnesota 33
Not applicableStudy completedNCT05818566
What this trial is testing

Orphan Drugs for Inherited Metabolic Diseases

Who this might be right for
Inborn Errors of Metabolism
University of Lausanne 39
Not applicableUnknownNCT02702375
What this trial is testing

Meta-analyses of Impotrant Food Sources of Sugars and Incident Cardiometabolic Diseases

Who this might be right for
Diabetes Mellitus, Type 2Metabolic Syndrome XHypertension+3 more
University of Toronto 1
Large-scale testing (Phase 3)Active Not RecruitingNCT05208281
What this trial is testing

A Multi-cohort Study of Safety, Efficacy, PK and PD of GNR-055 in Patients With Mucopolysaccharidosis Type II

Who this might be right for
Mucopolysaccharidosis Type IIMetabolic Diseases
AO GENERIUM 32
Not applicableStudy completedNCT02936713
What this trial is testing

Effect of Controlled Diet Combined With a Fermented Milk Product on Gas-related Symptoms

Who this might be right for
Functional Gastrointestinal Disorders
Danone Global Research & Innovation Center 126
Large-scale testing (Phase 3)Active Not RecruitingNCT06031259
What this trial is testing

Extension Study of Idursulfase-IT Along With Elaprase in Children and Adults With Hunter Syndrome and Cognitive Impairment

Who this might be right for
Hunter Syndrome
Takeda 6
Not applicableLooking for participantsNCT07653412
What this trial is testing

Precision Obesity Medicine: Genetic Prediction of Response to GLP-1/GIP Agonists.

Who this might be right for
Obesity (Disorder)Anti-obesity AgentsPrecision Medicine
National and Kapodistrian University of Athens 220
Not applicableStudy completedNCT01276275
What this trial is testing

Extended Drug Utilization Study Among Patients Exposed to Ticagrelor, Clopidogrel and Prasugrel

Who this might be right for
Bleeding ,Arrhythmias, Heart Failure, Acute Renal Failure, Acute Liver Failure, Dyspnoea, Gout
AstraZeneca 7,200
Not applicableLooking for participantsNCT06805695
What this trial is testing

Long-term Follow-up (LTFU) Study of Participants in Any iECURE Protocol Using an Investigational Product (IP)

Who this might be right for
Ornithine Transcarbamylase DeficiencyOrnithine Transcarbamylase Deficiency DiseaseUrea Cycle Disorders, Inborn
iECURE, Inc. 13
Early research (Phase 1)Study completedNCT03131583
What this trial is testing

The Drug-Drug Interaction of SHR4640, Febuxostat and Colchicine in Patients With Gout

Who this might be right for
Gout
Jiangsu HengRui Medicine Co., Ltd. 15
Not applicableStudy completedNCT00001771
What this trial is testing

I-123 Brain Studies of Serotonin Metabolism in Psychiatric Patients and Normal Volunteers

Who this might be right for
HealthyMental DisorderObsessive Compulsive Disorder+2 more
National Institute of Mental Health (NIMH) 112
Testing effectiveness (Phase 2)Study completedNCT02128490
What this trial is testing

Efficacy and Safety of Extended Release and Immediate Release Febuxostat in Participants With Gout and Moderate Renal Impairment

Who this might be right for
GoutModerate Renal Impairment
Takeda 189
Testing effectiveness (Phase 2)Study completedNCT03350451
What this trial is testing

An Extension Study of an Investigational Drug, Lumasiran (ALN-GO1), in Participants With Primary Hyperoxaluria Type 1

Who this might be right for
PH1Primary HyperoxaluriaRNAi Therapeutic+2 more
Alnylam Pharmaceuticals 20
Not applicableStudy completedNCT02000232
What this trial is testing

Impact of Unapproved Drug Initiative on Colchicine Use

Who this might be right for
Gout
Stanford University 185
Early research (Phase 1)Study completedNCT05899738
What this trial is testing

Compare the Relative Bioavailability of Two Iberdomide (CC-220) Formulations and to Assess The Effect Of Food on the Drug Levels of Iberdomide in Healthy Adult Participants

Who this might be right for
Healthy Volunteers
Bristol-Myers Squibb 32
Testing effectiveness (Phase 2)Study completedNCT01155778
What this trial is testing

Safety, Tolerability, Ascending Dose and Dose Frequency Study of rhHNS Via an IDDD in MPS IIIA Patients

Who this might be right for
Mucopolysaccharidosis (MPS)
Shire 12
Not applicableUnknownNCT01608620
What this trial is testing

Meta-analyses of Total and Individual Fructose-containing Sugars and Incident Cardiometabolic Disease

Who this might be right for
OverweightObesityDyslipidemia+9 more
John Sievenpiper 1
Early research (Phase 1)WithdrawnNCT04500548
What this trial is testing

Testing the Combination of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) in Children, Adolescent, and Young Adult Patients With Relapsed/Refractory Cancers That Have an Increased Number of Genetic Changes, The 3CI Study

Who this might be right for
Constitutional Mismatch Repair Deficiency SyndromeHematopoietic and Lymphoid Cell NeoplasmLynch Syndrome+9 more
National Cancer Institute (NCI)
Next Page